Shanyi Li

1.6k total citations · 1 hit paper
34 papers, 1.2k citations indexed

About

Shanyi Li is a scholar working on Molecular Biology, Surgery and Cancer Research. According to data from OpenAlex, Shanyi Li has authored 34 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 4 papers in Surgery and 4 papers in Cancer Research. Recurrent topics in Shanyi Li's work include Genomics, phytochemicals, and oxidative stress (14 papers), Epigenetics and DNA Methylation (5 papers) and Tissue Engineering and Regenerative Medicine (3 papers). Shanyi Li is often cited by papers focused on Genomics, phytochemicals, and oxidative stress (14 papers), Epigenetics and DNA Methylation (5 papers) and Tissue Engineering and Regenerative Medicine (3 papers). Shanyi Li collaborates with scholars based in United States, China and Netherlands. Shanyi Li's co-authors include Renyi Wu, Ah‐Ng Tony Kong, Hsiao‐Chen Dina Kuo, Lujing Wang, Rasika R. Hudlikar, Rebecca Mary Peter, Ran Yin, Davit Sargsyan, Pochung Jordan Chou and Ahmad Shannar and has published in prestigious journals such as PLoS ONE, Scientific Reports and Free Radical Biology and Medicine.

In The Last Decade

Shanyi Li

33 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

An Update on Current Therapeutic Drugs Treating COVID-19

2020 418 citations Renyi Wu, Lujing Wang et al. Current Pharmacology Reports profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shanyi Li United States	18	528	289	91	88	85	34	1.2k
Amjad Khan United Kingdom	22	567 1.1×	139 0.5×	208 2.3×	113 1.3×	61 0.7×	72	1.5k
Mahdi Hatamipour Iran	18	533 1.0×	156 0.5×	76 0.8×	33 0.4×	56 0.7×	37	1.6k
Ghazi A. Damanhouri Saudi Arabia	24	494 0.9×	130 0.4×	79 0.9×	27 0.3×	69 0.8×	67	1.7k
Rasika R. Hudlikar United States	15	403 0.8×	290 1.0×	76 0.8×	18 0.2×	86 1.0×	22	955
Hsiao‐Chen Dina Kuo United States	15	506 1.0×	290 1.0×	98 1.1×	17 0.2×	84 1.0×	26	1.0k
Mohamed El‐Mesery Egypt	21	460 0.9×	203 0.7×	110 1.2×	42 0.5×	102 1.2×	62	1.2k
Guohua An United States	25	581 1.1×	161 0.6×	56 0.6×	46 0.5×	35 0.4×	92	1.6k
W.S. Daniel Tan Singapore	19	497 0.9×	108 0.4×	115 1.3×	25 0.3×	39 0.5×	27	1.4k
Xunlong Shi China	23	689 1.3×	133 0.5×	69 0.8×	68 0.8×	30 0.4×	59	1.4k
Kyoung‐Jin Jang South Korea	16	468 0.9×	267 0.9×	92 1.0×	18 0.2×	34 0.4×	36	1.1k

Countries citing papers authored by Shanyi Li

Since Specialization

Citations

This map shows the geographic impact of Shanyi Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shanyi Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shanyi Li more than expected).

Fields of papers citing papers by Shanyi Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shanyi Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shanyi Li. The network helps show where Shanyi Li may publish in the future.

Co-authorship network of co-authors of Shanyi Li

This figure shows the co-authorship network connecting the top 25 collaborators of Shanyi Li. A scholar is included among the top collaborators of Shanyi Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shanyi Li. Shanyi Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Shanyi, et al.. (2025). Integrated Transcriptomic and Metabolomic Analyses in Characterizing the Anti‐Prostate Cancer Effects of Hederagenin. Journal of Biochemical and Molecular Toxicology. 39(8). e70425–e70425.

Yin, Ran, Davit Sargsyan, Renyi Wu, et al.. (2025). Microbiome and Metabolome Alterations in Nrf2 Knockout Mice With Induced Gut Inflammation and Fed With Phenethyl Isothiocyanate and Cranberry Enriched Diets. Molecular Nutrition & Food Research. 69(23). e70283–e70283. 1 indexed citations

Li, Shanyi, et al.. (2024). Ursolic Acid as a Protective Agent against UVB-Induced Metabolic and Epigenetic Alterations in Human Skin Keratinocytes: An Omics-Based Study. Cancer Prevention Research. 18(3). 135–144. 1 indexed citations

Chou, Pochung Jordan, Md Shahid Sarwar, Lujing Wang, et al.. (2023). Metabolomic, DNA Methylomic, and Transcriptomic Profiling of Suberoylanilide Hydroxamic Acid Effects on LPS-Exposed Lung Epithelial Cells. Cancer Prevention Research. 16(6). 321–332. 3 indexed citations

Chen, Xi, Fangming Yang, Yanjie Li, et al.. (2023). A network pharmacology and bioinformatics exploration of the possible molecular mechanisms of Fuzheng Xiaoliu Granule for the treatment of hepatocellular carcinoma. Journal of Clinical and Translational Research. 9(3). 182–194. 1 indexed citations

Minden, Audrey, Philip Furmanski, Min Ji Bak, et al.. (2020). Analysis of the Transcriptome: Regulation of Cancer Stemness in Breast Ductal Carcinoma In Situ by Vitamin D Compounds. Cancer Prevention Research. 13(8). 673–686. 13 indexed citations

Wang, Lujing, Wenji Li, David Cheng, et al.. (2020). Pharmacokinetics and pharmacodynamics of three oral formulations of curcumin in rats. Journal of Pharmacokinetics and Pharmacodynamics. 47(2). 131–144. 20 indexed citations

Wu, Renyi, Lujing Wang, Hsiao‐Chen Dina Kuo, et al.. (2020). An Update on Current Therapeutic Drugs Treating COVID-19. Current Pharmacology Reports. 6(3). 56–70. 418 indexed citations breakdown →

Wu, Renyi, Shanyi Li, Rasika R. Hudlikar, et al.. (2020). Redox signaling, mitochondrial metabolism, epigenetics and redox active phytochemicals. Free Radical Biology and Medicine. 179. 328–336. 35 indexed citations

10.

Li, Shanyi, Wenji Li, Chao Wang, et al.. (2019). Pelargonidin reduces the TPA induced transformation of mouse epidermal cells –potential involvement of Nrf2 promoter demethylation. Chemico-Biological Interactions. 309. 108701–108701. 34 indexed citations

11.

Kuo, Hsiao‐Chen Dina, Renyi Wu, Shanyi Li, Yuqing Yang, & Ah‐Ng Tony Kong. (2019). Anthocyanin Delphinidin Prevents Neoplastic Transformation of Mouse Skin JB6 P+ Cells: Epigenetic Re-activation of Nrf2-ARE Pathway. The AAPS Journal. 21(5). 83–83. 53 indexed citations

12.

Yin, Ran, Hsiao‐Chen Dina Kuo, Rasika R. Hudlikar, et al.. (2019). Gut Microbiota, Dietary Phytochemicals, and Benefits to Human Health. Current Pharmacology Reports. 5(5). 332–344. 73 indexed citations

13.

Wang, Chao, Renyi Wu, Davit Sargsyan, et al.. (2019). CpG methyl-seq and RNA-seq epigenomic and transcriptomic studies on the preventive effects of Moringa isothiocyanate in mouse epidermal JB6 cells induced by the tumor promoter TPA. The Journal of Nutritional Biochemistry. 68. 69–78. 23 indexed citations

14.

Yang, Yuqing, Renyi Wu, Davit Sargsyan, et al.. (2019). UVB drives different stages of epigenome alterations during progression of skin cancer. Cancer Letters. 449. 20–30. 48 indexed citations

15.

Guo, Yonglong, Quan Yu, Yunxia Xue, et al.. (2017). Cocktail of Chemical Compounds and Recombinant Proteins Robustly Promote the Stemness of Adipose-Derived Stem Cells. Cellular Reprogramming. 19(6). 363–371. 3 indexed citations

16.

Li, Shanyi, Zekai Cui, Deliang Zhu, et al.. (2017). In vitro biomimetic platforms featuring a perfusion system and 3D spheroid culture promote the construction of tissue-engineered corneal endothelial layers. Scientific Reports. 7(1). 777–777. 14 indexed citations

17.

Guo, Xiaoling, et al.. (2015). Enhanced viability and neural differential potential in poor post-thaw hADSCs by agarose multi-well dishes and spheroid culture. Human Cell. 28(4). 175–189. 17 indexed citations

18.

Liu, Qing, Yan Yang, Xiaoling Guo, et al.. (2014). The Effects of ROCK Inhibitor Y-27632 on Injectable Spheroids of Bovine Corneal Endothelial Cells. Cellular Reprogramming. 17(1). 77–87. 25 indexed citations

19.

Li, Shanyi, Chan Wang, Ying Dai, et al.. (2013). The stimulatory effect of ROCK inhibitor on bovine corneal endothelial cells. Tissue and Cell. 45(6). 387–396. 19 indexed citations

20.

Dai, Ying, Jiansu Chen, Hongyang Li, et al.. (2012). Characterizing the Effects of VPA, VC and RCCS on Rabbit Keratocytes onto Decellularized Bovine Cornea. PLoS ONE. 7(11). e50114–e50114. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact